Oragenics Inc. (AMEX:OGEN) price on Thursday, August 05, rose 4.10% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.74.
A look at the stock’s price movement, the close in the last trading session was $0.71, moving within a range at $0.69 and $0.75. The beta value (5-Year monthly) was 0.28. Turning to its 52-week performance, $1.80 and $0.38 were the 52-week high and 52-week low respectively. Overall, OGEN moved 14.79% over the past month.
Oragenics Inc.’s market cap currently stands at around $80.57 million. Analysts project the company’s earnings per share (EPS) to be -$0.04, which has seen fiscal year 2021 EPS growth forecast to increase to -$0.2 and about -$0.2 for fiscal year 2022.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that OGEN is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend OGEN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
OGEN’s current price about 8.54% and 5.05% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 53.68, while 7-day volatility ratio is 8.44% and 9.63% in the 30-day chart. Further, Oragenics Inc. (OGEN) has a beta value of 0.20, and an average true range (ATR) of 0.07.
In the market, a comparison of Oragenics Inc. (OGEN) and its peers suggest the former has performed considerably stronger. Data shows OGEN’s intraday price has changed 4.10% in last session and -34.82% over the past year. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are up 0.60% and 0.78% respectively in the last trading.
If we refocus on Oragenics Inc. (AMEX:OGEN), historical trading data shows that trading volumes averaged 35.87 million over the past 10 days and 6.33 million over the past 3 months. The company’s latest data on shares outstanding shows there are 115.64 million shares.
The 0.70% of Oragenics Inc.’s shares are in the hands of company insiders while institutional holders own 7.90% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.72 million on Jul 14, 2021, giving us a short ratio of 2.27. The data shows that as of Jul 14, 2021 short interest in Oragenics Inc. (OGEN) stood at 2.36% of shares outstanding, with shares short falling to 2.86 million registered in Jun 14, 2021. Current price change has pushed the stock 64.03% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the OGEN stock continues to rise going into the next quarter.